Skip to content

Management of Perumootu Vadham(Osteoarthritis of knee) with Varma massage, Amukkara Chooranam and Mudamirukki ennai

An Open Labelled Double arm Non - Randomized Phase II Clinical trial , to Compare Efficacy of Varma Massage with Amukkara Chooranam(Internal) and Mudamirukki Ennai (External) in the Management of Perumootu Vatham - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085367
Enrollment
40
Registered
2025-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: Varma Massage: Stimulation of Varma points by applying massage over the knee joint Control Intervention1: Amukkara Chooranam (Internal ) &Mudamirukki Ennai (External ): Internal Medicin

Sponsors

Government Siddha Medical College and Hospital ,Palayamkottai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient Having Symptoms of Joint Paint in one or both knee joints , swelling, tenderness, stiffness, crepitation and restricted movement of joints 2. Patient who are willing to give radiological investigation and provide blood for lab investigation 3. Patient who are willing to participate in this study with the knowledge of potential risks and who are willing to sign the informed consent form

Exclusion criteria

Exclusion criteria: 1. Age Below 35 years and above 70 years 2. History of Trauma to the joint 3. Other types of arthritis like rheumatoid arthritis , psoriatic arthritis, septic arthritis, reactive arthritis 4. History of uncontrolled diabetes 5. Pregnancy and lactating women 6. Benign and malignant neoplasm 7. Patient with any other autoimmune disease 8. Patient who are having any kind of skin disease

Design outcomes

Primary

MeasureTime frame
Assessment of change in symptoms from baseline in WOMAC Scale at end of studyTimepoint: 21 days

Secondary

MeasureTime frame
To Compare Efficacy of Group I & Group II & Pharmacological activity of the trial drugTimepoint: 78 Weeks

Countries

India

Contacts

Public ContactDr A MUNEESWARAN

Government Siddha Medical College and Hospital ,Palayamkottai , Tirunelveli

ameswar1968@gmail.com9443724897

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026